CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash Flows From Operating Activities
Net loss	$ (159,094)	$ (336,900)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	392,513	176,200
Bad debt expense	6,832	1,830
Deferred income tax benefit	(11,076)	(7,420)
Share-based compensation	3,054	26,344
Gain (Loss) on Disposition of Business	0	(1,052)
Deferred finance charges	9,050	3,140
Other operating activities	3,565	(3,902)
Changes in operating assets and liabilities:
Accounts receivable	114,038	129,398
Prepaid expenses	(887)	(13,335)
Other assets	60,749	62,818
Accounts payable	13,550	(8,394)
Accrued expenses and other current liabilities	90,439	(65,062)
Deferred revenues	(116,312)	(93,926)
Operating lease right of use assets	16,838	5,826
Operating lease liabilities	(37,362)	(6,611)
Other liabilities	2,905	2,077
Net cash provided by operating activities	305,515	128,022
Cash Flows From Investing Activities
Capital expenditures	(86,197)	(78,597)
Acquisitions, net of cash acquired	(14,314)	(885,323)
Acquisition of intangible assets	0	(5,982)
Proceeds from sale of product line, net of restricted cash	0	3,751
Net cash used in investing activities	(100,511)	(966,151)
Cash Flows From Financing Activities
Proceeds from Issuance of Long-term Debt	2,000,000
Principal payments on term loan	(21,450)	(9,450)
Repayments of revolving credit facility	0	(65,000)
Payment of debt issuance costs	(7,471)	(5,267)
Contingent purchase price payment	0	(4,115)
Proceeds from issuance of debt		360,000
Extinguishment of debt	(157,424)
Payments for Repurchase of Equity	(65,215)
Payments of Dividends	(1)
Proceeds from issuance of ordinary shares	728,080	843,752
Proceeds from Issuance of Convertible Preferred Stock	1,392,671
Proceeds from warrant exercises	0	277,526
Proceeds from stock options exercised	17,250	1,307
Payments related to tax withholding for stock-based compensation	(21,455)	(28,674)
Net cash provided by financing activities	3,864,985	1,370,079
Effects of exchange rates	(4,860)	(6,447)
Net increase in cash and cash equivalents, and restricted cash	4,065,129	525,503
Cash:
Cash and cash equivalents	2,479,880	601,075
Restricted cash	1,857,657	567
Total cash and cash equivalents, and restricted cash	4,337,537	601,642
Supplemental Cash Flow Information:
Cash paid for interest	97,401	61,796
Cash paid for income tax	22,387	20,147
Capital expenditures included in accounts payable	6,612	922
Stock Issued	62,724
Noncash Financing Items [Abstract]
Treasury Stock, Retired, Cost Method, Amount	(5,117,380)
Gain (Loss) on Foreign Currency Forward Contracts	4,026	(2,903)
Mark to Market Loss on Contingent Shares	(25,085)	30,839
Fair Value Adjustment of Warrants	(113,207)	224,175
Noncash Impairment, Leases	50,979	$ 4,880
DRG
Noncash Financing Items [Abstract]
Value of stock issued	$ 61,619